Osteoporosis and sarcopenia in patients with rheumatoid arthritis: the ways to prevent musculoskeletal loss
- Authors: Muradyants A.A1, Shostak N.A1, Kondrashov A.A1, Timofeev V.T1
-
Affiliations:
- N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
- Issue: Vol 18, No 2 (2016)
- Pages: 134-140
- Section: Articles
- URL: https://journals.rcsi.science/2075-1753/article/view/94501
- ID: 94501
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
A. A Muradyants
N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Email: elitarsoft@list.ru
канд. мед. наук, доц. каф. факультетской терапии им. акад. А.И.Нестерова лечебного фак-та ГБОУ ВПО РНИМУ им. Н.И.Пирогова 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
N. A Shostak
N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Email: shostakkaf@yandex.ru
д-р мед. наук, проф., зав. каф. факультетской терапии им. акад. А.И.Нестерова лечебного фак-та ГБОУ ВПО РНИМУ им. Н.И.Пирогова 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
A. A Kondrashov
N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Email: kaartem@gmail.com
ассистент каф. факультетской терапии им. акад. А.И.Нестерова лечебного фак-та ГБОУ ВПО РНИМУ им. Н.И.Пирогова 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
V. T Timofeev
N.I.Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Email: vtt3@yandex.ru
д-р мед. наук, глав. науч. сотр. научно- исследовательской лаб. «Ревматические заболевания» каф. факультетской терапии им. акад. А.И.Нестерова лечебного фак-та ГБОУ ВПО РНИМУ им. Н.И.Пирогова 117997, Russian Federation, Moscow, ul. Ostrovitianova, d. 1
References
- Ревматология. Клинические рекомендации. Под ред. Е.Л.Насонова. М.:ГЭОТАР-Медиа, 2010; с. 90-230.
- Мikuls T.R, Fay B.T, Michaud K et al. Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry. Rheumatology (Oxford) 2011; 50: 101-9.
- Насонов Е.Л., Скрипникова И.А., Насонова В.А. Проблема остеопороза в ревматологии. М.: Стин, 1997.
- Gough A.K, Lilley J, Eyre S et al. Generalized bone loss in patient with early rheumatoid arthritis. Lancet 1994; 344 (8914): 23-7.
- Goldring S.R. The effects of inflammatory arthritis on bone remodeling. Arthritis Res 2005; 7 (Suppl. 1): S12.
- Bezerra M.C, Carvalho J.F, Prokopowitsch A.S, Pereira R.M. RANK, RANKL and osteoprotegerin in arthritic bone loss. Braz J Med Biol Res 2005; 38 (2): 161-70
- Forsblad d'Elia H, Larsen A, Waltbrand E et al. Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis. Ann Rheum Dis 2003; 62 (7): 617-23.
- Solomon D.H, Finkelstein J.S, Shadick N et al. The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis: the osteoporosis in rheumatoid arthritis (OPiRA) cohort study. Arthr Rheum 2009; 60: 1624-31.
- Fardellone P, Séjourné A, Paccou J, Goëb V. Bone Remodelling Markers in Rheumatoid Arthritis. Med Inflam 2014, Article ID 484280. http://dx.doi.org/10.1155/2014/484280
- Таскина Е.А., Алексеева Л.И., Дыдыкина И.С. и др. Факторы риска развития остеопороза у больных ревматоидным артритом. Науч. - практ. ревматология. 2014; 52 (4): 393-7.
- Гукасян Д.А., Балабанова Р.М., Смирнов А.В., Насонов Е.Л. Изучение взаимосвязи между минеральной плотностью костной ткани и клинико - лабораторными показателями активности ревматоидного артрита. Науч. - практ. ревматология. 2005; 1: 18-21.
- Sinigaglia L, Nervetti A, Mela Q et al. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol 2000; 27: 2582-9.
- Güler-Yüksel M, Allaart C.F, Goekoop-Ruiterman Y.P et al. Changes in hand and generalised bone mineral density in patients with recent - onset rheumatoid arthritis. Ann Rheum Dis 2009; 68 (3): 330-6.
- Deodhar A.A, Woolf A.D. Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol 1996; 35 (4): 309-22.
- Мурадянц А.А., Шостак Н.А. Вторичный остеопороз: особенности течения и терапии при ревматоидном артрите. Вестн. РГМУ. 2005; 8 (47): 70-4.
- Беневоленская Л.И. Проблема остеопороза в современной медицине. Науч. - практ. ревматология. 2005; 1: 4-7.
- Haugeberg G, Strand A, Kvien T.K, Kirwan J.R. Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis: results from a randomized placebo - controlled trial. Arch Intern Med 2005; 165 (11): 1293-7.
- Habib G.S, Haj S. Bone mineral density in patients with early rheumatoid arthritis treated with corticosteroids. Clin Rheumatol 2005; 24 (2): 129-33.
- Kanis J.A, Burlet N, Cooper C et al. European guidance for the diagnosis and management of оsteoporosis in postmenopausal women. Osteoporos Int 2008; 19: 399-428.
- Van Staa T.P, Geusens P, Bijlsma J.W et al. Clinical assessment of the long - term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 2006, 54: 3104-12.
- Evans W.J, Morley J.E, Argiles J et al. Cachexia: a new defenition. Clin Nutr 2008; 27 (6): 793-9.
- Cruz-Jentoft A.J, Baeyens J.P, Bauer J.M et al. Sarcopenia: European consensus on definition and diagnosis Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39 (4): 412-23.
- Baumgartner R.N, Koehler K.M, Romero L.J et al. Epidemiology of sarcopenia in elderly people in New Mexico. Am J Epidemiol 1998; 147: 744-63.
- Roubenoff R. Sarcopenia: effects on body composition and function. J Gerontol A Biol Sci Med Sci 2003; 58 (11): 1012-7.
- Giles J.T, Allison M, Blumenthal R.S et al. Abdominal adiposity in rheumatoid arthritis: Association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum 2010; 62 (11): 3173-82.
- Marcora S.M, Chester K.R, Mittal G et al. Randomized phase 2 trial of anti - tumor necrosis factor therapy for cachexia in patients with early rheumatoid arthritis. Am J Clin Nutr 2006; 84: 1463-72.
- Crepaldi G, Maggi S. Sarcopenia and osteoporosis: A hazardous duet. J Endocrinol Invest 2005; 28 (10): 66-8.
- Binkley N, Buehring B. Beyond FRAX: it's time to consider "sarco - osteopenia". J Clin Densitom 2009; 12: 413-6.
- Drey M, Sieber C.C, Bertsch T et al. Osteosarcopenia is more than sarcopenia and osteopenia alone. Aging Clin Exp Res 2015 Nov 12. [Epub ahead of print]
- Walsh M.C, Hunter G.R, Livingstone M.B. Sarcopenia in premenopausal and postmenopausal women with osteopenia, osteoporosis and normal bone mineral density. Osteoporos Int 2006; 17: 61-7.
- Di Monaco M, Vallero F, Di Monaco R, Tappero R. Prevalence of sarcopenia and its association with osteoporosis in 313 older women following a hip fracture. Arch Gerontol Geriatr 2011; 52: 71-4.
- Kostoglou-Athanassiou I, Athanassiou P, Lyraki A et al. Vitamin D and rheumatoid arthritis. Ther Adv Endocrinol Metab 2012; 3 (6): 181-7.
- Burton L.A, Sumukadas D. Optimal management of sarcopenia. Clin Interv Aging 2010; 5: 217-28.
- Jankosky C, Deussing E, Gibson R, Haverkos H. Viruses and vitamin D in the etiology of type 1 diabetes mellitus and multiple sclerosis. Virus Res 2012; 163: 424-30.
- Smolen J.S, Breedveld F.C, Burmester G.R et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis 2016; 75 (1): 3-15.
- Vis M, Güler-Yüksel M, Lems W.F. Can bone loss in rheumatoid arthritis be prevented? Osteoporosis Int 2013; 24 (10): 2541-53.
- Minaur N.J, Kounali D, Vedi S et al. Methotrexate in the treatment of rheumatoid arthritis. II. In vivo effects on bone mineral density. Rheumatol (Oxford) 2002; 41 (7): 741-9.
- Di Munno O, Mazzantini M, Sinigaglia L et al. Effect of low dose methotrexate on bone density in women with rheumatoid arthritis: results from a multicenter cross - sectional study. J Rheumatol 2004; 31 (7): 1305-9.
- O’Dell J.R, Mikuls T.R, Taylor T.H et al. Therapies for active rheumatoid arthritis after methotrexate failure. N Engl J Med 2013; 369 (4): 307-18.
- Kobayashi Y, Ueyama S, Arai Y et al. The active metabolite of leflunomide, A771726, inhibits both the generation of and the bone - resorbing activity of osteoclasts by acting directly on cells of the osteoclast lineage. J Bone Miner Metab 2004; 22 (4): 318-28.
- Sakthiswary R, Das S. The effects of TNF a antagonist therapy on bone metabolism in rheumatoid arthritis: a systematic review. Curr Drug Targ 2013; 14 (13): 1552-7.
- Chopin F, Garnero P, le Henanff A et al. Long - term effects of infliximab on bone and cartilage turnover markers in patients with rheumatoid arthritis. Ann Rheum Dis 2008; 67 (3): 353-7.
- Kim S.Y, Schneeweiss S, Liu J et al. Effects of disease - modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: A population - based cohort study. J Bone Min Res 2012; 27 (4): 789-96.
- Kume K, Amano K, Yamada S et al. The effect of tocilizumab on bone mineral density in patients with methotrexate - resistant active rheumatoid arthritis. Rheumatol 2014; 53 (5): 900-3.
- Garnero P, Thompson E, Woodworth T et al. Rapid and sustained improvement in bone and cartilage turnover markers with the anti - interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double - blind, placebo - controlled trial of tocilizumab in inadequate responders to methotrexate alone. Arthritis Rheum 2010; 62 (1): 33-43.
- Wheater G, Hogan V.E, Teng Y.K et al. Suppression of bone turnover by B-cell depletion in patients with rheumatoid arthritis. Osteoporosis Int 2011; 22 (12): 3067-72.
- Klein R.G, Arnaud S.B, Gallagher J.C et al. Intestinal absorption in exogenous hypercortisolism: role of 25-hydroxyvitamin D and corticosteroid dose. J Clin Invest 1977; 60: 253-9.
- Reid I.R, Bolland M.J, Grey A. Effects of vitamin D supplements on bone mineral density: a systematic review and meta - analysis. Lancet 2014; 383 (9912): 146-55.
- Avenell A, Mak J.C, O’Connell D. Vitamin D and vitamin D analogues for preventing fractures in post m enopausal women and older men. Cochrane Database Syst Rev 2014; 4.
- Gallagher J.C, Sai A, Templin T et al. Dose response to vitamin D supplementation in postmenopausal women: a randomized trial. Annals of Internal Medicine 2012; 156 (6): 425-37.
- Van Hemelrijck M, Michaelsson K, Linseisen J et al. Calcium intake and serum concentration in relation to risk of cardiovascular death in NHANES III. PLoS One 2013; 8 (4): e61037.
- Choy E, Ganeshalingam K, Semb A.G et al. Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. Rheumatol 2014; 53 (12): 2143-54.
- Nieves J.W. Skeletal effects of nutrients and nutraceuticals, beyond calcium and vitamin D. Osteoporos Int 2013; 24 (3): 771-86.
- Okyay E, Ertugrul C, Acar B et al. Comparative evaluation of serum levels of main minerals and postmenopausal osteoporosis. Maturitas 2013; 76 (4): 320-5.
- Zheng J, Mao X, Ling J et al. Low serum levels of zinc, copper, and iron as risk factors for osteoporosis: a meta - analysis. Biol Trace Elem Res 2014; 160 (1): 15-23.
- Nielsen F.H, Hunt C.D, Mullen L.M et al. Effect of dietary boron on mineral, estrogen, and testosterone metabolism in postmenopausal women. FASEB 1987; J1: 394-7.
- Демидов В.И., Жидоморов Н.Ю., Громова О.А. и др. Роль кальция, витамина D3 и остеотропных минералов в профилактике и комплексном лечении перелома берцовой кости: результаты рандомизированного плацебо - контролируемого эксперимента. Лечащий врач. 2014; 12.
- Evstigneyeva L, Kozhemyakina E, Lesnyak O et al. Effect of Exercise for Patient with Osteoporotic Vertebral Fractures. Ann Rheum Dis 2013; 72 (Suppl. 3): A137-A1372.
- De Jong Z, Munneke M, Lems W.F et al. Slowing of bone loss in patients with rheumatoid arthritis by long - term high - intensity exercise: results of a randomized, controlled trial. Arthritis Rheum 2004; 50 (4): 1066-76.
- Lemmey A.B, Williams S.L, Marcora . et al. Are the benefits of a high - intensity progressive resistance training program sustained in rheumatoid arthritis patients? A 3-year followup study. Arthritis Care Res 2012; 64 (1): 71-5.
- Lemmey A.B, Marcora ., Chester K et al. Effects of high - intensity resistance training in patients with rheumatoid arthritis: A randomized controlled trial. Arthritis Care Res 2009; 61 (12): 1726-34.
- Rall L.C, Meydani ., Kehayias . et al. The effect of progressive resistance training in rheumatoid arthritis. Increased strength without changes in energy balance or body composition. Arthritis Rheum 1996; 39 (3): 415-26.
- Waters D.L, Baumgartner R.N, Garry P.J et al. Advantages of dietary, exercise - related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update. Clin Interv Aging 2010; 5: 259-70.
- Romas E. Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates. Best Pract Res Clin Rheum 2005; 19 (6): 1065-79.
- Suzuki Y. Secondary osteoporosis. Bisphosphonates as a possible strategy for the prevention of bone destruction in rheumatoid arthritis. Clin Calcium 2007; 17 (12): 1909-13.
- Sambrook P.N, Cameron I.D, Chen J.S et al. Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five - year study. Osteopor Int 2011; 22 (9): 2551-6.